A Nonimmunosuppressant Approach on Asia Psoriasis Subjects: 5-Year Followup and 11-Year Data Analysis
Figure 6
Evolution of psoriasis lesion in patients with prior immunosuppressants therapy. (a) Month 0. Photograph before initiating herose. (b) Month 1. (c) Month 2. (d) Month 3. (e) Month 4. (f) Month 5. (g) Month 6. (h) Month 9. (i) Month 12. (j) Month 18. (k) Month 26. (l) Month 32. Patient experienced 200% worsening of PASI score from month 1 (b) to month 6 (g) relative to baseline value (a), which was the immunosuppressants withdrawal syndrome, the severity of psoriasis flared up to a high point, but henceforth progressively tapered down, flakes exfoliated from psoriatic lesion reduced in size and finer flakes shed off, psoriatic plaques became thinner as shown at month 18 (j), improvement of PASI75 was achieved at month 26 (k), psoriatic plaques eradicated, and the subsided lesion area faded to a greyish colour (k, l).
